T. Rowe Price Associates’s Aprea Therapeutics APRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,494	Closed	-$147K	–	2839
2020 Q4	$147K	Sell	1,494 -13,714	-90%	-$1.35M	﹤0.01%	2587
2020 Q3	$7.32M	Sell	15,208 -532	-3%	-$256K	﹤0.01%	1358
2020 Q2	$12.2M	Buy	+15,740	New	+$12.2M	﹤0.01%	1253